DexCom, Inc.
DXCM
Rang in Aktien
#758
DexCom, Inc. is a medical technology company primarily focused on innovating,... DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
Aktienkurs
$85.98
Zuletzt synchronisiert: 2026-10-16
Marktkapitalisierung
$32.45B
Veränderung (1 Tag)
-1.97%
Veränderung (1 Jahr)
29.10%
Land
US
Handel DexCom, Inc. (DXCM)
Kategorie
Healthcare
EPS für DexCom, Inc. (DXCM)
EPS zum June 2026 TTM: $2.59
Laut den aktuellen Finanzberichten und dem Aktienkurs von DexCom, Inc. beträgt das aktuelle EPS des Unternehmens (TTM) $2.59. Am Ende des Jahres 2024 betrug das EPS $1.46 eine Steigerung gegenüber dem EPS von 2023, das $1.44 betrug.
EPS-Verlauf von DexCom, Inc. von 2000 bis 2026
EPS am Ende jedes Jahres
| Jahr | EPS | ändert |
|---|---|---|
| 2026 (TTM) | $2.59 | 21.03% |
| 2025 | $2.14 | 46.58% |
| 2024 | $1.46 | 1.39% |
| 2023 | $1.44 | 63.64% |
| 2022 | $0.88 | 57.14% |
| 2021 | $0.56 | -57.25% |
| 2020 | $1.31 | 367.86% |
| 2019 | $0.28 | -177.78% |
| 2018 | $-0.36 | 140.00% |
| 2017 | $-0.15 | -25.00% |
| 2016 | $-0.20 | 11.11% |
| 2015 | $-0.18 | 141.61% |
| 2014 | $-0.07 | -25.50% |
| 2013 | $-0.10 | -50.00% |
| 2012 | $-0.20 | 17.65% |
| 2011 | $-0.17 | -29.17% |
| 2010 | $-0.24 | -20.00% |
| 2009 | $-0.30 | -36.17% |
| 2008 | $-0.47 | 14.63% |
| 2007 | $-0.41 | -4.65% |
| 2006 | $-0.43 | 4.88% |
| 2005 | $-0.41 | -73.20% |
| 2004 | $-1.53 | 34.21% |
| 2003 | $-1.14 | 21.28% |
| 2002 | $-0.94 | 13.25% |
| 2001 | $-0.83 | 45.61% |
| 2000 | $-0.57 | 0.00% |
EPS für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | EPS | EPS-Differenz | Land |
|---|---|---|---|
| $3.11 | 20.08% |
US
|
|
| $3.59 | 38.61% |
IE
|
|
| $9.73 | 275.68% |
US
|
|
| $2.48 | -4.25% |
US
|
|
| - | - |
DE
|
